Published in Women's Health Weekly, March 12th, 2009
"Given this, strategies that limit resistance by sensitizing cells to tamoxifen may be of use in the clinic. To gain insight into how this might be achieved, We used Chemical and genetic screens to identify targets and small-molecule inhibitors that Cause tamoxifen sensitization. A high-throughput genetic Screen, using an RNA interference library targeting 779 kinases and related proteins,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.